Case Report: Tropical sprue, diagnostic challenges of an old but unrecognized disease

Introduction

Tropical sprue (TS) is a very old disease. The first reported cases were described by a Yorkshireman, Dr William Hillary, among the inhabitants of the island of Barbados over 200 years ago.¹ Endemic TS occurs in the tropical and subtropical regions but is underrecognized elsewhere. It is predominantly present in southern and southeast Asia and the Caribbean Islands, and rarely described in North Africa and Europe. Within the present era of globalization and worldwide travel, it is important for all clinicians to be aware of the possibility of TS in patients presenting with diarrhea, malabsorption, multiple nutritional deficiencies and mucosal abnormalities in the small bowel who have travelled to endemic regions.²

Diagnosis of TS remains challenging since it can be confused with common diarrheal diseases, including celiac disease, Crohn’s disease, bacterial overgrowth, and other infectious aetiologies.³

In this article, we present a Tunisian case of latent TS revealed by a confusional syndrome.

Case report

A 58-year-old North African male was admitted to the intensive care unit for confusion without fever. He was single, working as a trader and had a history of iron deficiency anemia. There were no particular family antecedents. The acute symptoms had been preceded by chronic diarrhea, worsening fatigue, and a 40 pounds weight loss over three years which were trivialized by the patient. He had neither HIV nor tuberculosis risk factors.

Physical examination revealed conjunctival pallor, diffuse abdominal pain and dehydration without fever or organomegaly. Blood glucose levels were normal, as well as the urine dipstick.

Blood tests identified metabolic acidosis (Ph = 7.35, paCO₂ = 22.9 mmHg, HCO₃^- = 12.9 mmol/L, paO₂ = 88 mmHg) with normal anion gap which was related to gastrointestinal loss of bicarbonate. We also noted normochromic normocytic anemia (haemoglobin = 5.7 g/dL, MCV = 81 fl, MCHC = 30 g/dL), and normal WBC (7200/μL) and platelet (174000/μL) counts. Renal and liver functions were correct (creatinine = 72 μmol/L, total bilirubin = 13.6 μmol/L, AST/ALT/ALP = 31/31/140 IU/L). The blood ionogram showed hypokalaemia (2.81 mmol/L) and hypophosphatemia (0.32 mmol/L) with normal natremia (139 mmol/L) and chloremia (110 mmol/L). Additional investigations revealed normal level of vitamin B1, negative viral serologies (Hbs, HCV and HIV) and negative toxicology work-up. Brain MRI and abdominal CT scan were normals.

The most likely cause of confusion was the severe metabolic acidosis after ruling out cerebral causes, toxic causes, uraemia, hepatic encephalopathy, and Gayet wernicke encephalopathy (no chronic alcoholism, no diabetes history and normal level of vitamin B1). Furthermore, we noted an improvement on the state of consciousness after hydro-electrolytic resuscitation and acid-base disorders correction. Despite the neurological improvement, the patient continued to have watery diarrhea, abdominal meteorism and weight loss. Thus, he was treated for a possible small bowel bacterial overgrowth with an association of a third generation cephalosporin and metronidazole. However, he continued to have three-five loose stools daily.

A nutritional assessment was performed and showed a malabsorption syndrome: iron deficiency (ferritin = 0.84 μg/L, serum iron = 2.44 μmol/L), hypoalbuminemia (22 g/L) and hypocalcaemia (1.8 mmol/L). We also noticed slight deficiencies in Vitamin B12: 170 pg/mL (normal: 180-914 pg/mL) and folate: 3.2 μg/L (normal > 3.5 μg/L).

Upper gastrointestinal endoscopy showed partial villous atrophy (Figure 1). These changes were nonspecific but were suggestive of celiac disease. Thus, a gluten-free diet was prescribed.

Figure 1. Gastrointestinal endoscopy showing duodenal villous atrophy.

Duodenal biopsy showed subtotal villous atrophy with increased intraepithelial lymphocytosis and a very thickened hyalonalized sub-epithelial basal lamina: an appearance suggestive of sprue (Figure 2).

Figure 2. Histological findings.

On re-interviewing, we discovered that the patient had spent two months in India (for commercial purposes) three years prior. A few months after his return, he developed chronic intermittent watery, non-bloody diarrhea. He was also experiencing asthenia and had a weight loss but he did not consult any doctor.

Celiac serologies, including endomysial antibody, tissue transglutaminase antibody, and gliadin IgA, gliadin IgG, and total IgA levels were all negative. In light of these negative serologies and lack of response to a gluten-free diet, celiac disease was unlikely. Given the travel history, clinico-biological, endoscopic and histological findings, TS was highly considered.

A five-month antibiotic course was prescribed (tetracycline 250 mg four times daily) combined to a nutritional supplementation (iron: 150 mg and folate: 5 mg orally daily with cyanocobalamin 1000 μg daily intramuscularly for ten days, followed by 1000 μg monthly for one year). Within one month the patient reported feeling significantly better with resolution of diarrhea, increased energy and weight gain. The biochemical parameters had normalized at the three-month check-up (haemoglobin = 9.4 g/dL, and albumin = 43 g/L). The response to treatment supported the diagnosis of TS.

On the one-year follow-up visit, the patient was continuing to improve. He gained 35 pounds of weight and the diarrhea was completely gone.

Discussion

The main strengths associated to this case report of TS were: the uncommon presentation of TS which was revealed by a confusional syndrome; and the clinico-biological, endoscopic and histological features supporting this rare and unrecognized diagnosis in non-endemic areas. Response to combined treatment confirmed the diagnosis but the lack of an endoscopic control after improvement was a limitation in our case. In fact, TS is a disease of the small intestine characterized by a malabsorption syndrome with a subtotal or partial mucosal atrophy. It occurs mainly in the tropics, particularly in most of the Greater Antilles, the northern part of South and Central America and South-East Asia. It appears to be rare in Africa, but its real frequency is unknown as small bowel biopsies are not routinely done.⁴ TS affects indigenous inhabitants and expatriates, either long-term residents or short-term visitors, in these endemic areas (the case of our patient).^4,5 Patients can present with diarrhea soon after returning from the tropics, but rarely TS may be latent for months to years after leaving the endemic region, as was the case of our patient.⁶

The risk factors involved in the pathogenesis of this small bowel disease are immune deficiency, poor hygiene, and bacterial, viral or parasitic gastrointestinal infections.³ In fact, the most incriminated bacteria are Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae.^7,8 Enterotoxin production by some strains of enterotoxigenic K. pneumonia or E. coli can lead to abnormalities of mucosal structure and function.⁴ Otherwise, the local action of unabsorbed bile acids might also be involved.³

The diagnosis of TS is difficult. It is based on the combination of clinico-biological, histological and evolutionary criteria:^3,7,9

Therefore, TS must be considered in patients who have lived in an endemic area, presenting with chronic diarrhea and evidence of malabsorption. Megaloblastic anemia is common and is secondary to folate and vitamin B12 deficiencies. Associated iron deficiency may turn a macrocytic anemia into a normocytic anemia. This could explain the normochromic normocytic anemia of our patient further, since he had a history of iron deficiency anemia. Calcium, vitamin D and magnesium-impaired absorption may also occur, with resulting osteopenia. Steatorrhea is often evident if fecal fat is measured. Furthermore, abnormal D-xylose test supports proximal small intestine malabsorption.^3,4,6,9,10

Gastrointestinal endoscopic findings are non-specific in TS. In fact, celiac disease must be considered, especially given the endoscopic abnormalities and histological similarity with TS.⁸ Biopsy from the distal portion of the duodenum reveals villous atrophy and an increased infiltration of the lamina propria by chronic inflammatory cells (plasma cells and lymphocytes).⁸ Other causes of malabsorption (celiac disease, Crohn’s disease, bacterial overgrowth and lymphoma) must be ruled out.^3,4,9

The key principles in the management of TS include rehydration, micronutrient deficiency replacement, oral folate, intramuscular vitamin B12 and antibiotics. Sulfonamides and, more recently, new quinolones, particularly ofloxacin, were tried in some previous cases reported in the literature. However, tetracycline is the antibiotic of choice, administered at a dose of 250 mg orally four times daily.^3,4,8,9,11 The duration of treatment has not yet been codified, as it depends on the evolution of the disease. In general, it’s a prolonged antibiotic course over three to six months. It will be stopped after control of the restitution ad integrum of the clinico-biological and histological anomalies.^8,9,12 In our case, tetracycline was prescribed for five months and the favourable response to treatment supported the diagnosis of TS, but a control by gastrointestinal endoscopy wasn’t carried out.

Complete resolution after an optimal management is standard in the returning travellers from an endemic area. However, for the tropics inhabitants, TS may relapse, requiring a prolonged follow-up given the risk of re-exposure to the infectious agent.^3,6,8,12

Conclusions

Clinico-biological, endoscopic and histological findings overlap between TS and other malabsorption diseases, explaining diagnosis difficulties. While TS is common in tropics inhabitants, it must be considered in tropics visitors presenting with chronic diarrhea after ruling out other causes. Improvement after an optimal management combining rehydration, replacement of micronutrient, folate and vitamin B12 deficiencies as well as a prolonged antibiotic course supports the diagnosis of TS.

Data availability

All data underlying the results are available as part of the article and no additional source data are required.

Consent

Written informed consent for publication of the clinical details and clinical images was obtained from the patient.